Last reviewed · How we verify
NCT03091842
Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer
NA trial testing Exercise Intervention in Cancer Survivor. Withdrawn.
29 July 2024
Quick facts
| Lead sponsor | University of Southern California |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Start date | 29 July 2019 |
| Primary completion | 29 July 2024 |
| Estimated completion | 29 July 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Exercise Intervention
- Exercise Intervention
- Exercise Intervention
- Informational Intervention
- Laboratory Biomarker Analysis — full drug profile →
- Quality-of-Life Assessment
- Questionnaire Administration
Conditions studied
- Cancer Survivor — all drugs for Cancer Survivor →
- Central Obesity — all drugs for Central Obesity →
- Estrogen Receptor Positive — all drugs for Estrogen Receptor Positive →
- Postmenopausal — all drugs for Postmenopausal →
Sponsor
University of Southern California
Who can join
18 and older, female only, with Cancer Survivor or Central Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized phase II trial studies how well exercise intervention works in targeting adiposity and inflammation with movement to improve prognosis in stage I-III breast cancer survivors. Different types of exercise may reduce inflammation in fat tissue and minimize the risk of cancer recurrence related to being overweight or obese.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Body weight management in overweight and obese breast cancer survivors.
Shaikh H, Bradhurst P, Ma LX, Tan SYC, et al · · 2020 · cited 66× · PMID 33305350 · DOI 10.1002/14651858.cd012110.pub2 -
Epidemiology and biology of physical activity and cancer recurrence.
Friedenreich CM, Shaw E, Neilson HK, Brenner DR. · · 2017 · cited 65× · PMID 28620703 · DOI 10.1007/s00109-017-1558-9 -
Obesity and Breast Cancer: The Role of Crown-Like Structures in Breast Adipose Tissue in Tumor Progression, Prognosis, and Therapy.
Faria SS, Corrêa LH, Heyn GS, de Sant'Ana LP, et al · · 2020 · cited 43× · PMID 32595986 · DOI 10.4048/jbc.2020.23.e35 -
Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors (The AIM Trial): Rationale, Design, and Methods.
Kang DW, Wilson RL, Gonzalo-Encabo P, Norris MK, et al · · 2022 · cited 1× · PMID 35795051 · DOI 10.3389/fonc.2022.896995
Verify or expand the search:
- PubMed search for NCT03091842
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exercise Intervention
Trials testing the same drug.
- NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · NA · not yet recruiting
- NCT06565260 — Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors · NA · recruiting
- NCT07302230 — Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Amon · NA · recruiting
- NCT07340281 — Biomarkers for Exercise · NA · recruiting
- NCT07504835 — GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer · NA · not yet recruiting
Other recruiting trials for Cancer Survivor
Currently open trials in the same condition.
- NCT06894849 — Text -Based Depression Screening Among Cancer Survivors · NA · recruiting
- NCT06868524 — Leading Healthy Eating and Activity Promotion Program · NA · recruiting
- NCT06574009 — Better Options for Chronic Cancer Pain · Phase 4 · recruiting
- NCT06939322 — LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study) · NA · recruiting
- NCT06814977 — An Acupuncture Study for Cancer Survivors With Joint Pain · NA · recruiting
Other University of Southern California trials
Trials by the same sponsor.
- NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
- NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
- NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
- NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
- NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03091842 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern California
- Last refreshed: 24 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03091842.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing